Risk assessment model based on nucleotide metabolism-related genes highlights slc27a2 as a potential therapeutic target in breast cancer

HIGHLIGHTS

• What: The authors aimed to identify specific NMRGs to develop a prognostic model for predicting outcomes in patients with BC. The research provides evidence that SLC27A2 plays an important role in BC development, making it a potential target in BC therapy. The research investigated the potential prognosis biomarkers of BC, establishing a BC nucleotide metabolism signature. Although the research has identified a correlation between nucleotide metabolism-related molecules and the prognosis of BC for the first time, there are still some limitations to this study.
• Who: Bo Zhang from the Department of Thyroid, Breast and . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or E-mail:

  If you don't have an account, you can create one here.